Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy

The development of the nanosized delivery systems with targeting navigation and efficient cargo release for cancer therapy has attracted great attention in recent years. Herein, a folic acid (FA) modified PEGylated polycaprolactone containing ditelluride linkage was synthesized through a facile coup...

Full description

Bibliographic Details
Main Authors: Zekun Pang, Jiayan Zhou, Chunyang Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Chemistry
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fchem.2020.00156/full
id doaj-53dfc5544f4d452bb608a94c3a7662c4
record_format Article
spelling doaj-53dfc5544f4d452bb608a94c3a7662c42020-11-25T02:50:05ZengFrontiers Media S.A.Frontiers in Chemistry2296-26462020-02-01810.3389/fchem.2020.00156528115Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer TherapyZekun PangJiayan ZhouChunyang SunThe development of the nanosized delivery systems with targeting navigation and efficient cargo release for cancer therapy has attracted great attention in recent years. Herein, a folic acid (FA) modified PEGylated polycaprolactone containing ditelluride linkage was synthesized through a facile coupling reaction. The hydrophobic doxorubicin (DOX) can be encapsulated into the polymeric micelles, and such nanoparticles (F-TeNPDOX) exhibited redox-responsive drug release under abundant glutathione (GSH) condition due to the degradation of ditelluride bonds. In addition, flow cytometric analyses showed that the FA ligands on F-TeNPDOX could facilitate their cellular uptake in 4T1 breast cancer cells. Therefore, F-TeNPDOX led to the promoted drug accumulation and enhanced growth inhibition on 4T1 tumor in vivo. The obtained results suggest F-TeNPDOX excellent potential as nanocarriers for anticancer drug delivery.https://www.frontiersin.org/article/10.3389/fchem.2020.00156/fullditelluride linkageredox responsivetargeted nanoparticledrug deliverycancer therapy
collection DOAJ
language English
format Article
sources DOAJ
author Zekun Pang
Jiayan Zhou
Chunyang Sun
spellingShingle Zekun Pang
Jiayan Zhou
Chunyang Sun
Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy
Frontiers in Chemistry
ditelluride linkage
redox responsive
targeted nanoparticle
drug delivery
cancer therapy
author_facet Zekun Pang
Jiayan Zhou
Chunyang Sun
author_sort Zekun Pang
title Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy
title_short Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy
title_full Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy
title_fullStr Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy
title_full_unstemmed Ditelluride-Bridged PEG-PCL Copolymer as Folic Acid-Targeted and Redox-Responsive Nanoparticles for Enhanced Cancer Therapy
title_sort ditelluride-bridged peg-pcl copolymer as folic acid-targeted and redox-responsive nanoparticles for enhanced cancer therapy
publisher Frontiers Media S.A.
series Frontiers in Chemistry
issn 2296-2646
publishDate 2020-02-01
description The development of the nanosized delivery systems with targeting navigation and efficient cargo release for cancer therapy has attracted great attention in recent years. Herein, a folic acid (FA) modified PEGylated polycaprolactone containing ditelluride linkage was synthesized through a facile coupling reaction. The hydrophobic doxorubicin (DOX) can be encapsulated into the polymeric micelles, and such nanoparticles (F-TeNPDOX) exhibited redox-responsive drug release under abundant glutathione (GSH) condition due to the degradation of ditelluride bonds. In addition, flow cytometric analyses showed that the FA ligands on F-TeNPDOX could facilitate their cellular uptake in 4T1 breast cancer cells. Therefore, F-TeNPDOX led to the promoted drug accumulation and enhanced growth inhibition on 4T1 tumor in vivo. The obtained results suggest F-TeNPDOX excellent potential as nanocarriers for anticancer drug delivery.
topic ditelluride linkage
redox responsive
targeted nanoparticle
drug delivery
cancer therapy
url https://www.frontiersin.org/article/10.3389/fchem.2020.00156/full
work_keys_str_mv AT zekunpang ditelluridebridgedpegpclcopolymerasfolicacidtargetedandredoxresponsivenanoparticlesforenhancedcancertherapy
AT jiayanzhou ditelluridebridgedpegpclcopolymerasfolicacidtargetedandredoxresponsivenanoparticlesforenhancedcancertherapy
AT chunyangsun ditelluridebridgedpegpclcopolymerasfolicacidtargetedandredoxresponsivenanoparticlesforenhancedcancertherapy
_version_ 1724740306297946112